Accurate and timely diagnosis is critical for dengue patient management due
to no specific treatment is available for the disease. The use of rapid diagnostic tests
(RDTs) could assist in disease screening because of their simplicity and inexpensiveness
but nonetheless, the performance of these tests needs to be carefully evaluated. Here,
we report the performance of RVR Dengue Combo NS1-IgG/IgM Rapid Test for detection
of dengue NS1 antigen and dengue-specific IgM using 98 samples that were screened
initially using Panbio Dengue IgM Capture ELISA and Panbio Dengue Early Rapid Test.
The positive percent agreement (PPA) between RVR Dengue Combo NS1-IgG/IgM Rapid
Test and the reference comparator tests was 77.8% and negative percent agreement
(NPA) was 95.7% for NS1 (κ=0.748, P